+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Rituxan - Product Thumbnail Image

Rituxan

  • Report
  • January 2019
  • 82 Pages
From
From
From
From
Global Scleroderma Treatment Market 2017-2021 - Product Thumbnail Image

Global Scleroderma Treatment Market 2017-2021

  • Report
  • June 2017
  • 83 Pages
From
From
From
From
From
From
From
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2020 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2020

  • Drug Pipelines
  • January 2020
  • 374 Pages
From
Loading Indicator
adroll